Transfusion Patients with Hereditary Hemorrhagic Telangiectasia Have Increased Risk of Alloimmunization Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominate disorder characterized by arteriovenous malformations. In patients… March 7, 2018
RBC and Plasma Transfusions Continue to Decline among US Hospitalizations Based on data from the National Inpatient Sample from 1993 through 2014, hospitalized patients receiving at least one unit of… February 27, 2018
Intravenous Iron Supplementation Increases Hemoglobin and Iron Levels in Female Blood Donors Since iron deficiency in blood donors is a common problem and compliance for taking oral iron supplements may be challenging,… February 20, 2018
Anemia During Pregnancy Increases the Risk of RBC Transfusions After Delivery for New Moms Fifteen to thirty percent of pregnant women are diagnosed with anemia (hemoglobin [Hb] less than 11.0 g/dL) and are at… February 14, 2018
High-Throughput Exome Sequencing Clarifies Serology Typing and Helps Identify Rare and Novel Blood Group Alleles Next Generation Sequencing (NGS), also known as high-throughput sequencing and massively parallel sequencing, is a revolutionary sequencing technique that amplifies… February 7, 2018
Alloimmunization to One RBC Antigen Triggers Alloimmunization to Other RBC Antigens The risk of alloimmunization to polymorphic RBC antigens is high for individuals who undergo chronic transfusion therapy. Researchers recently utilized… January 31, 2018
Global Variations in Blood Safety and Availability Based on WHO Report Every two years since 1998 the World Health Organization (WHO) has collected data on blood safety and availability. The WHO… January 24, 2018
Cell Salvage for Cesarean Sections Cell savage, the collection and return of lost autologous blood during surgery, is frequently used in cardiothoracic and vascular surgeries…. January 17, 2018
RBC Transfusions for Palliative Care Patients Palliative care is a proactive and personalized approach for improving physical and spiritual problems in terminally ill patients. Cancer patients… January 9, 2018
Successful Treatment of Refractory B-cell Lymphomas with CAR T-Cell Therapy Chimeric antigen receptor (CAR) T-cell therapy has been shown to successfully treat refractory B-cell lymphomas. Two new studies published in… January 3, 2018
